Logiscreen

Roivant Sciences Ltd

$28.58
Market Cap 20.45B
ROE -6.9%
Gross Margin 87.3%
Debt/Equity 0.0
Current Ratio 18.4
Revenue QoQ -66.7%
EPS QoQ -2.6%
F-Score 4

About

Roivant Sciences Ltd

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-70.50
vs median 33.61
P/B
4.67
vs median 2.16
ROE
-0.07
vs median 0.09

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Similar companies

BNTXMRNAINCYINSMUTHRGMAB
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics